Palisade Bio, Inc.

NasdaqCM:PALI Stock Report

Market Cap: US$222.0m

Palisade Bio Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:PALI Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Jan 26BuyUS$8,356Donald WilliamsIndividual5,000US$1.67
09 Jan 26BuyUS$9,400Donald WilliamsIndividual5,000US$1.88

Insider Trading Volume

Insider Buying: PALI insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of PALI?
Owner TypeNumber of SharesOwnership Percentage
Private Companies510.0000342%
Individual Insiders31,9070.0214%
VC/PE Firms12,050,0008.09%
Hedge Funds34,735,95223.3%
Institutions50,012,69933.6%
General Public52,172,60135%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 5287%.


Top Shareholders

Top 25 shareholders own 64.98% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
16%
Janus Henderson Group plc
23,782,928US$35.4m0%0.01%
8.09%
Perceptive Advisors LLC
12,050,000US$18.0m0%0.4%
6.42%
Octagon Capital Advisors LP
9,567,898US$14.3m0%1.76%
6.26%
Commodore Capital LP
9,332,443US$13.9m0%0.57%
6.15%
Franklin Resources, Inc.
9,163,990US$13.7m0%no data
5.54%
Squadron Capital Management Llc
8,250,000US$12.3m0%no data
5.09%
Point72 Asset Management, L.P.
7,585,611US$11.3m0%0.02%
4.78%
RA Capital Management, L.P.
7,124,116US$10.6m0%0.11%
4.31%
Deep Track Capital, LP
6,428,571US$9.6m0%0.17%
1.42%
The Vanguard Group, Inc.
2,115,622US$3.2m46,500%no data
0.45%
Columbia Management Investment Advisers, LLC
669,982US$998.3k0%no data
0.32%
Armistice Capital LLC
478,945US$713.6k0%0.02%
0.06%
FMR LLC
89,915US$134.0k0%no data
0.031%
Virtus Investment Advisers, LLC
46,000US$68.5k0%no data
0.02%
Two Sigma Securities, LLC
29,406US$43.8k84.1%0.01%
0.018%
Geode Capital Management, LLC
26,620US$39.7k7.63%no data
0.01%
NFSG Corporation
15,000US$22.4k15.4%no data
0.0095%
XTX Markets Limited
14,085US$21.0k-48.5%no data
0.0092%
Donald Williams
13,728US$20.4k268%no data
0.009%
J. Finley
13,472US$20.1k-0.01%no data
0.0067%
FNY Investment Advisers, LLC
9,951US$14.8k0%no data
0.0058%
Morgan Stanley
8,618US$12.8k123,000%no data
0.0036%
Tower Research Capital Europe Limited
5,396US$8.0k18.2%no data
0.0026%
Mitchell Jones
3,852US$5.8k0%no data
0.0016%
Citigroup Inc.
2,347US$3.5k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/02/02 22:17
End of Day Share Price 2026/02/02 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Palisade Bio, Inc. is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
William WoodB. Riley Securities, Inc.
Kumaraguru RajaBrookline Capital Markets
Aydin HuseynovLadenburg Thalmann & Company